Brett Lund - Gevo President
| GEVO Stock | USD 0.60 0.02 3.23% |
President
Mr. Brett Lund, J.D., is Chief Legal Officer, General Counsel, and Secretary of Gevo, Inc. effective November 2014. In 2013, Mr. Lund has served as General Counsel and Secretary of the Company since November 2007 and as Chief Legal Officer since November 2014. In 2013, Mr. Lund was named Forty Under 40 by the Denver Business Journal for being one of top forty business leaders under age 40. In 2012, Mr. Lund was named one of the Most Influential Young Professionals in Colorado by ColoradoBiz Magazine and also in 2012, Mr. Lund was named Best Corporationrationrate Counsel by the Denver Business Journal. Before joining the Company, from 2004 to 2007, he served as Chairman of the legal, intellectual property and licensing group and biotechnology licensing manager for the biofuels business of Syngenta Biotechnology, Inc. . At Syngenta, Mr. Lund led the management of intellectual property, inlicensing, outlicensing, research collaborations and strategic alliances. In 2006, Mr. Lund was Chief Executive Officer and a member of the board of Agarigen, Inc. where he developed a novel protein expression platform for biologic pharmaceuticals, vaccines, and commercial enzymes. At Agarigen, Mr. Lund worked on a multimillion dollar research program for the Defense Advanced Research Projects Agency and later led the sale of Agarigen to Intrexon, Inc. . Prior to Agarigen, he served as Associate General Counsel for Ford Motor Company, Inc.s Wingcast subsidiary since 2014.
| Age | 38 |
| Tenure | 10 years |
| Professional Marks | MBA |
| Address | Building C, Englewood, CO, United States, 80112 |
| Phone | 303 858 8358 |
| Web | https://www.gevo.com |
Gevo Management Efficiency
The company has return on total asset (ROA) of (0.0757) % which means that it has lost $0.0757 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1139) %, meaning that it created substantial loss on money invested by shareholders. Gevo's management efficiency ratios could be used to measure how well Gevo manages its routine affairs as well as how well it operates its assets and liabilities. As of the 19th of April 2024, Return On Tangible Assets is likely to drop to -0.11. In addition to that, Return On Capital Employed is likely to drop to -0.15. At this time, Gevo's Intangible Assets are very stable compared to the past year.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Christopher Mecray | Axalta Coating Systems | N/A | |
| Steven Markevich | Axalta Coating Systems | 58 | |
| Wilbur Mok | Air Products and | 63 | |
| Aaron Weis | Axalta Coating Systems | N/A | |
| Netha Johnson | Albemarle Corp | 53 | |
| Gregory Riddle | Eastman Chemical | 55 | |
| John Barichivich | Albemarle Corp | 53 | |
| Michael Crocco | Air Products and | 58 | |
| Clark Jordan | Eastman Chemical | 59 | |
| Corning Painter | Air Products and | 54 | |
| Frank Biot | Sociedad Quimica y | N/A | |
| David Heflin | Axalta Coating Systems | N/A | |
| Scot Benson | Element Solutions | 58 | |
| Scott King | Eastman Chemical | 51 | |
| Michael Wondrasch | Avantor | 54 | |
| Samir Serhan | Air Products and | 63 | |
| Donald LaBauve | Albemarle Corp | 57 | |
| Godefroy Motte | Eastman Chemical | 56 | |
| Thomas Szlosek | Avantor | 60 | |
| Eduardo Menezes | Linde plc Ordinary | 56 | |
| Sean Lannon | Axalta Coating Systems | 45 | |
Management Performance
| Return On Equity | -0.11 | ||||
| Return On Asset | -0.0757 |
Gevo Inc Leadership Team
Elected by the shareholders, the Gevo's board of directors comprises two types of representatives: Gevo inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Gevo. The board's role is to monitor Gevo's management team and ensure that shareholders' interests are well served. Gevo's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Gevo's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Brett Lund, Executive Vice President General Counsel, Secretary | ||
| Dr MBA, CEO Director | ||
| Geoffrey Williams, General Counsel, Secretary | ||
| Heather Manuel, Vice Communications | ||
| Shawn Severson, IR Contact Officer | ||
| Nancy Young, Chief Officer | ||
| Michael Willis, CFO, Executive Vice President of Corporate Development and Strategy | ||
| Andy Marsh, Director | ||
| Timothy Cesarek, Chief Officer | ||
| Kimberly SPHR, Chief Officer | ||
| Gary Mize, Independent Director | ||
| William Baum, Director | ||
| Gregory Roda, Chief Commercial Officer | ||
| Andrew Shafer, Customer Marketing | ||
| Frances Arnold, Co-Founder, Consultant and Member of Scientific Advisory Board | ||
| Bradford Towne, Principal Financial Officer, Principal Accounting Officer | ||
| David George, Senior Tracking | ||
| Ruth Dreessen, Independent Director | ||
| Prof Liao, CoFounder | ||
| Damien Perriman, Chief Officer | ||
| Patrick Gruber, CEO, Director | ||
| Alisher CPA, Principal Accounting | ||
| Andrew Marsh, Independent Director | ||
| Johannes Roth, Director | ||
| Greg Roda, Chief Commercial Officer | ||
| Tim Cesarek, Executive Vice President and Chief Commercial Officer | ||
| Paul Bloom, Chief Officer | ||
| Williams BA, Gen VP | ||
| Mike Willis, CFO, Principal Accounting Officer and Executive VP of Corporate Devel. and Strategy | ||
| Christopher Ryan, President, COO and CTO | ||
| Lynn Smull, Chief Officer |
Gevo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Gevo a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.11 | ||||
| Return On Asset | -0.0757 | ||||
| Operating Margin | (4.88) % | ||||
| Current Valuation | (87.02 M) | ||||
| Shares Outstanding | 241.78 M | ||||
| Shares Owned By Insiders | 3.45 % | ||||
| Shares Owned By Institutions | 37.16 % | ||||
| Number Of Shares Shorted | 31.39 M | ||||
| Price To Earning | (0.22) X | ||||
| Price To Book | 0.27 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gevo Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Gevo Stock analysis
When running Gevo's price analysis, check to measure Gevo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gevo is operating at the current time. Most of Gevo's value examination focuses on studying past and present price action to predict the probability of Gevo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gevo's price. Additionally, you may evaluate how the addition of Gevo to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Gevo's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gevo. If investors know Gevo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gevo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.28) | Revenue Per Share 0.072 | Quarterly Revenue Growth 7.026 | Return On Assets (0.08) | Return On Equity (0.11) |
The market value of Gevo Inc is measured differently than its book value, which is the value of Gevo that is recorded on the company's balance sheet. Investors also form their own opinion of Gevo's value that differs from its market value or its book value, called intrinsic value, which is Gevo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gevo's market value can be influenced by many factors that don't directly affect Gevo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gevo's value and its price as these two are different measures arrived at by different means. Investors typically determine if Gevo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gevo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.